Phase-2 #msg-39142514Top-line data from EMINENCE trial #msg-31058048 Clinicaltrials.gov entry for EMINENCE trial #msg-26897189 *Overview of planned phase-2 program
Phase-1 #msg-28193368 Phase-1 results with IV administration #msg-31057367 Phase-1 results with sub-Q administration #msg-31027378 Drug-interaction study with aspirin and Plavix